Cargando…

Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe

BACKGROUND: Cervical cancer is the fourth cancer worldwide. The Human Papilloma Virus is responsible for 99% of the cases but the distribution of its genotypes varies among populations. We aimed to identify HPV genotypes distribution in women with grade 2/3 cervical intraepithelial dysplasia or inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaete, Stanie, Auguste, Aviane, Bhakkan, Bernard, Peruvien, Jessica, Herrmann-Storck, Cecile, Socrier, Youri, Diedhiou, Abdoulaye, Deloumeaux, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962384/
https://www.ncbi.nlm.nih.gov/pubmed/33726684
http://dx.doi.org/10.1186/s12885-021-07940-3
_version_ 1783665458971410432
author Gaete, Stanie
Auguste, Aviane
Bhakkan, Bernard
Peruvien, Jessica
Herrmann-Storck, Cecile
Socrier, Youri
Diedhiou, Abdoulaye
Deloumeaux, Jacqueline
author_facet Gaete, Stanie
Auguste, Aviane
Bhakkan, Bernard
Peruvien, Jessica
Herrmann-Storck, Cecile
Socrier, Youri
Diedhiou, Abdoulaye
Deloumeaux, Jacqueline
author_sort Gaete, Stanie
collection PubMed
description BACKGROUND: Cervical cancer is the fourth cancer worldwide. The Human Papilloma Virus is responsible for 99% of the cases but the distribution of its genotypes varies among populations. We aimed to identify HPV genotypes distribution in women with grade 2/3 cervical intraepithelial dysplasia or invasive cervical cancer in Guadeloupe, a French Caribbean territory with a population mainly of African descent. METHODS: We used paraffin-embedded tumors for viral DNA extraction from women diagnosed between 2014 and 2016 and identified by the population-based cancer registry. The HPV Genotyping was performed with the InnoLIPA HPV Genotyping Extra kit®. RESULTS: Overall, 213 samples out of the 321 eligible records were analyzed. The HPV status was positive for 94% of the cases. The five most common oncogenic HPV genotypes were HPV31 (47%), HPV33 (38%), HPV16 (32%), HPV44 (31%) and HPV26 (28%). HPV18 was found in only in 5% of the cases. Among the studied cases, 94% had multiple infections. More than 60% of single infections were HPV16-related, accounting for 35% of HPV16 infections. CONCLUSIONS: These results show a different distribution of oncogenic HPVs in Guadeloupe with “31 >  33 > 16” and a high frequency of multiple infections. Despite a lower coverage, the nine-valent vaccine is nevertheless adequate.
format Online
Article
Text
id pubmed-7962384
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79623842021-03-16 Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe Gaete, Stanie Auguste, Aviane Bhakkan, Bernard Peruvien, Jessica Herrmann-Storck, Cecile Socrier, Youri Diedhiou, Abdoulaye Deloumeaux, Jacqueline BMC Cancer Research Article BACKGROUND: Cervical cancer is the fourth cancer worldwide. The Human Papilloma Virus is responsible for 99% of the cases but the distribution of its genotypes varies among populations. We aimed to identify HPV genotypes distribution in women with grade 2/3 cervical intraepithelial dysplasia or invasive cervical cancer in Guadeloupe, a French Caribbean territory with a population mainly of African descent. METHODS: We used paraffin-embedded tumors for viral DNA extraction from women diagnosed between 2014 and 2016 and identified by the population-based cancer registry. The HPV Genotyping was performed with the InnoLIPA HPV Genotyping Extra kit®. RESULTS: Overall, 213 samples out of the 321 eligible records were analyzed. The HPV status was positive for 94% of the cases. The five most common oncogenic HPV genotypes were HPV31 (47%), HPV33 (38%), HPV16 (32%), HPV44 (31%) and HPV26 (28%). HPV18 was found in only in 5% of the cases. Among the studied cases, 94% had multiple infections. More than 60% of single infections were HPV16-related, accounting for 35% of HPV16 infections. CONCLUSIONS: These results show a different distribution of oncogenic HPVs in Guadeloupe with “31 >  33 > 16” and a high frequency of multiple infections. Despite a lower coverage, the nine-valent vaccine is nevertheless adequate. BioMed Central 2021-03-16 /pmc/articles/PMC7962384/ /pubmed/33726684 http://dx.doi.org/10.1186/s12885-021-07940-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Gaete, Stanie
Auguste, Aviane
Bhakkan, Bernard
Peruvien, Jessica
Herrmann-Storck, Cecile
Socrier, Youri
Diedhiou, Abdoulaye
Deloumeaux, Jacqueline
Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title_full Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title_fullStr Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title_full_unstemmed Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title_short Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
title_sort frequent high-risk hpv co-infections excluding types 16 or 18 in cervical neoplasia in guadeloupe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962384/
https://www.ncbi.nlm.nih.gov/pubmed/33726684
http://dx.doi.org/10.1186/s12885-021-07940-3
work_keys_str_mv AT gaetestanie frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT augusteaviane frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT bhakkanbernard frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT peruvienjessica frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT herrmannstorckcecile frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT socrieryouri frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT diedhiouabdoulaye frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe
AT deloumeauxjacqueline frequenthighriskhpvcoinfectionsexcludingtypes16or18incervicalneoplasiainguadeloupe